ScripThe big respiratory players will be casting envious glances at the launch of Verona Pharma’s chronic obstructive pulmonary disorder (COPD) drug, Ohtuvayre, which is going from strength to strength. Th
Pink SheetEleven of Viatris’ products have been halted from entering the US after the firm’s oral finished dose manufacturing facility in Indore, India received a US Food and Drug Administration warning letter
Generics BulletinEleven of Viatris’ products have been halted from entering the US after the firm’s oral finished dose manufacturing facility in Indore, India was subject to a US Food and Drug Administration warning l
ScripIdorsia’s hopes of signing a global licensing deal for its hypertension drug Tryvio before the end of the year have been dashed, leaving the cash-strapped Swiss biotech to weigh up “all strategic opti